| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:09:11 UTC |
|---|
| Update date | 2020-09-17 15:30:59 UTC |
|---|
| Primary ID | FDB010547 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Myo-Inositol |
|---|
| Description | Myo-Inositol is an inositol isoform. Inositol is a derivative of cyclohexane with six hydroxyl groups, making it a polyol. It also is known as a sugar alcohol, having the same molecular formula as glucose or other hexoses. Inositol exists in nine possible stereoisomers, including scyllo-inositol, myo-inositol (the most abundant), muco-inositol, D-chiro-inositol, L-chiro-inositol, neo-inositol, allo-inositol, epi-inositol, and cis-inositol. In humans, most inositol is synthesized in the kidneys, typically in amounts of a few grams per day. It is found in many foods, particularly in cereals with high bran content. It is an isomer of glucose that has traditionally been a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in humans. Inositol is a cyclic polyalcohol that plays an important role as a second messenger in a cell, in the form of inositol phosphates. Inositol phospholipids are important in signal transduction. A possible health effect of inositols, including myo-inositol, was recently reviewed. The review concluded that myo-inositol, together with chiro-inositol, at a 40:1 ratio, were an important therapeutic strategy for the improvement of metabolic, hormonal, and reproductive aspects of polycystic ovarian syndrome (PMID: 29309199). |
|---|
| CAS Number | 87-89-8 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| (1R,2R,3S,4S,5R,6S)-Cyclohexane-1,2,3,4,5,6-hexol | ChEBI | | 1,2,3,4,5,6-HEXAHYDROXY-cyclohexane | ChEBI | | 1,2,3,5/4,6-cyclohexanehexol | ChEBI | | 1D-Myo-inositol | ChEBI | | 1l-Myo-inositol | ChEBI | | Bios I | ChEBI | | cis-1,2,3,5-trans-4,6-Cyclohexanehexol | ChEBI | | Cyclohexitol | ChEBI | | D-Myo-inositol | ChEBI | | Dambose | ChEBI | | I-inositol | ChEBI | | Inosite | ChEBI | | Inositol | ChEBI | | Ins | ChEBI | | L-Myo-inositol | ChEBI | | Meat sugar | ChEBI | | Meso-inositol | ChEBI | | Myoinositol | ChEBI | | Inosital | Kegg | | Iso-inositol | HMDB | | MI | HMDB | | Myoinosite | HMDB | | Phaseomannite | HMDB | | Rat antispectacled eye factor | HMDB | | Myo inositol | HMDB | | Vitamin b8 | HMDB | | Myo-inositol | HMDB | | (1a,2a,3a,4b,5a,6b)-Cyclohexanehexol | db_source | | 1,2,3,5/4,6-Inositol | db_source | | 1D-myo-Inositol | ChEBI | | 1L-myo-Inositol | ChEBI | | D-myo-Inositol | ChEBI | | i-Inositol | db_source | | L-myo-Inositol | ChEBI | | meso-Inositol | db_source | | Nucitol | db_source |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C6H12O6 |
|---|
| IUPAC name | (1R,2R,3r,4S,5S,6s)-cyclohexane-1,2,3,4,5,6-hexol |
|---|
| InChI Identifier | InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H/t1-,2-,3-,4+,5-,6- |
|---|
| InChI Key | CDAISMWEOUEBRE-GPIVLXJGSA-N |
|---|
| Isomeric SMILES | O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O |
|---|
| Average Molecular Weight | 180.1559 |
|---|
| Monoisotopic Molecular Weight | 180.063388116 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as cyclohexanols. Cyclohexanols are compounds containing an alcohol group attached to a cyclohexane ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic oxygen compounds |
|---|
| Class | Organooxygen compounds |
|---|
| Sub Class | Alcohols and polyols |
|---|
| Direct Parent | Cyclohexanols |
|---|
| Alternative Parents | |
|---|
| Substituents | - Cyclohexanol
- Sugar alcohol
- Cyclitol or derivatives
- Cyclic alcohol
- Polyol
- Hydrocarbon derivative
- Aliphatic homomonocyclic compound
|
|---|
| Molecular Framework | Aliphatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
|
| Physiological effect | Health effect: |
|---|
| Disposition | Route of exposure: Source: Biological location: |
|---|
| Role | Industrial application: Biological role: |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Solid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 40.00%; H 6.71%; O 53.28% | DFC |
|---|
| Melting Point | Mp 225° | DFC |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | 143 mg/mL at 19 oC | YALKOWSKY,SH & DANNENFELSER,RM (1992) |
|---|
| Experimental logP | Not Available | |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | 0 | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | | Type | Description | Splash Key | View |
|---|
| GC-MS | Myo-Inositol, 6 TMS, GC-MS Spectrum | splash10-014j-0953000000-1571a0577293e96091b1 | Spectrum | | GC-MS | Myo-Inositol, 6 TMS, GC-MS Spectrum | splash10-00kb-0932000000-96ddc21293431d746ad2 | Spectrum | | GC-MS | Myo-Inositol, non-derivatized, GC-MS Spectrum | splash10-00kb-0942000000-b78076224adf13bade25 | Spectrum | | GC-MS | Myo-Inositol, non-derivatized, GC-MS Spectrum | splash10-00kb-0942000000-42c4e40d04b4f306535d | Spectrum | | GC-MS | Myo-Inositol, 6 TMS, GC-MS Spectrum | splash10-00di-8942000000-f5d7abd38d6ff547a0a9 | Spectrum | | GC-MS | Myo-Inositol, 6 TMS, GC-MS Spectrum | splash10-066r-0975000000-df7304c12b6c9bdb0f76 | Spectrum | | GC-MS | Myo-Inositol, non-derivatized, GC-MS Spectrum | splash10-014j-0953000000-1571a0577293e96091b1 | Spectrum | | GC-MS | Myo-Inositol, non-derivatized, GC-MS Spectrum | splash10-00kb-0932000000-96ddc21293431d746ad2 | Spectrum | | GC-MS | Myo-Inositol, non-derivatized, GC-MS Spectrum | splash10-00kb-0942000000-b78076224adf13bade25 | Spectrum | | GC-MS | Myo-Inositol, non-derivatized, GC-MS Spectrum | splash10-00di-8942000000-f5d7abd38d6ff547a0a9 | Spectrum | | GC-MS | Myo-Inositol, non-derivatized, GC-MS Spectrum | splash10-066r-0975000000-df7304c12b6c9bdb0f76 | Spectrum | | Predicted GC-MS | Myo-Inositol, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-03dr-9700000000-18a13ab4150e6ebb20cd | Spectrum | | Predicted GC-MS | Myo-Inositol, 6 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-00fr-9001040000-00e67b437c4329aee95d | Spectrum | | Predicted GC-MS | Myo-Inositol, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Myo-Inositol, TMS_1_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Myo-Inositol, TMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Myo-Inositol, TMS_1_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Myo-Inositol, TMS_1_4, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Myo-Inositol, TMS_1_5, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Myo-Inositol, TMS_1_6, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Myo-Inositol, TMS_2_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Myo-Inositol, TMS_2_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Myo-Inositol, TMS_2_3, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Myo-Inositol, TMS_2_4, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | | Predicted GC-MS | Myo-Inositol, TMS_2_5, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, N/A (Annotated) | splash10-0a59-3900000000-96084971c3e13a1e7451 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, N/A (Annotated) | splash10-001i-9000000000-1de17d7f53ca727e6d72 | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, N/A (Annotated) | splash10-0zh9-9000000000-bef910214341056a78aa | 2012-07-24 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 2V, negative | splash10-004i-0900000000-41a49af846b1636763b5 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 2V, negative | splash10-004i-0900000000-06f9ecfccf30d40ef204 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 3V, negative | splash10-004i-0900000000-bca88f6782a8ed386223 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 4V, negative | splash10-004i-1900000000-500ab195d69568b8678b | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 5V, negative | splash10-01ti-5900000000-a1657b54c985e2be1d19 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 6V, negative | splash10-000i-9600000000-325cbb8dbfdeafb2b31f | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 8V, negative | splash10-000i-9200000000-9145a4766351204e723a | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 9V, negative | splash10-000i-9100000000-2bbbcfa4733b749ec768 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 10V, negative | splash10-000i-9000000000-de0ec8731a152b612bb9 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 12V, negative | splash10-0079-9000000000-41d049d1feef94e190d4 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 14V, negative | splash10-059i-9000000000-796e728daf28d5122dee | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 15V, negative | splash10-059i-9000000000-8643e206319f3008a8d4 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 18V, negative | splash10-0abi-9000000000-98e61f19bc2842f2e97b | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - Orbitrap 20V, negative | splash10-0ab9-9000000000-29aa062fc4d5341167b6 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - n/a 12V, negative | splash10-03di-1900000000-5a2897fd032a959918b3 | 2020-07-22 | View Spectrum | | MS/MS | LC-MS/MS Spectrum - n/a 12V, negative | splash10-000i-9000000000-71c4786b7034d5a0a0a9 | 2020-07-22 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-001i-0900000000-5cb39f92646251665ebf | 2016-09-12 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-001i-0900000000-2aeb7708f31c772e2d95 | 2016-09-12 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-08gi-8900000000-74f89711a1c6891808a4 | 2016-09-12 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-004i-0900000000-8b68ff47f846a8ca1ddd | 2016-09-12 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-004i-1900000000-03ef8572289795275d9c | 2016-09-12 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0570-9300000000-950a37bd331028801e9f | 2016-09-12 | View Spectrum |
|
|---|
| NMR | | Type | Description | | View |
|---|
| 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 125 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, D2O, experimental) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, experimental) | | Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | | Spectrum | | 2D NMR | [1H, 1H]-TOCSY. Unexported temporarily by An Chi on Oct 15, 2021 until json or nmrML file is generated. 2D NMR Spectrum (experimental) | | Spectrum | | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | | Spectrum |
|
|---|
| External Links |
|---|
| ChemSpider ID | 10239179 |
|---|
| ChEMBL ID | CHEMBL1222251 |
|---|
| KEGG Compound ID | C00137 |
|---|
| Pubchem Compound ID | Not Available |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | 17268 |
|---|
| Phenol-Explorer ID | Not Available |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB00211 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | FCS22-I:FCS22-I |
|---|
| EAFUS ID | 1795 |
|---|
| Dr. Duke ID | MYO-INOSITOL|INOSITOL|MESO-INOSITOL |
|---|
| BIGG ID | 33990 |
|---|
| KNApSAcK ID | C00001164 |
|---|
| HET ID | INS |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Inositol |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Anti-alopecic | 52217 | An agent that promotes hair growth and prevents hair loss, commonly used to treat alopecia and other hair-related disorders, by inhibiting dihydrotestosterone (DHT) and stimulating hair follicle growth. | DUKE | | Anti-cirrhotic | 52217 | An agent that prevents or treats liver cirrhosis, reducing fibrosis and promoting liver health. It inhibits liver scarring, commonly used in managing liver diseases such as hepatitis and fatty liver disease. | DUKE | | Anti-diabetic | 52217 | An agent that regulates blood sugar levels, enhancing insulin sensitivity or secretion. Therapeutically, it's used to manage diabetes, reducing symptoms and complications, and commonly prescribed to treat type 1 and 2 diabetes, as well as gestational diabetes. | DUKE | | Anti neuropathic | | An agent that relieves symptoms such as pain, numbness, and tingling caused by damage or disease affecting the somatosensory nervous system, commonly used in managing conditions like diabetes, shingles, and nerve injuries. | DUKE | | Cholesterolytic | | An enzyme that breaks down cholesterol, playing a key biological role in lipid metabolism. Therapeutically, it has applications in managing hypercholesterolemia and atherosclerosis, with potential uses in cardiovascular disease prevention and treatment. | DUKE | | Lipotropic | | A compound that facilitates fat breakdown and metabolism, playing a biological role in lipid utilization. Therapeutically, it's used to enhance weight loss and improve liver function. Key medical applications include treating fatty liver disease, obesity, and hyperlipidemia, making it a valuable agent in managing metabolic disorders. | DUKE | | Sweetener | 50505 | A substance that adds sweetness to food and beverages, often used as a sugar substitute. Its biological role is to stimulate taste receptors, while its therapeutic applications include managing calorie intake and blood sugar levels. Key medical uses include treating diabetes and obesity, as well as reducing tooth decay risk. | DUKE | | Ubiquiot | | An antioxidant that protects cells from damage, playing a crucial role in energy production. Therapeutically, it has applications in managing neurodegenerative and cardiovascular diseases, with key medical uses including reducing oxidative stress and improving mitochondrial function. | DUKE |
|
|---|
| Enzymes | | Name | Gene Name | UniProt ID |
|---|
| Alpha-galactosidase A | GLA | P06280 |
|
|---|
| Pathways | |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | show |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004). — Shinbo, Y., et al. 'KNApSAcK: a comprehensive species-metabolite relationship database.' Plant Metabolomics. Springer Berlin Heidelberg, 2006. 165-181.
|
|---|